With over 20 years of diverse experience across bioinformatics, genomics, software development, and digital forensics, I am a seasoned professional with a track record of spearheading and delivering innovative projects. At Illumina, I have spent more than a decade leading critical initiatives, including the development of Nirvana, a state-of-the-art variant annotator, which has had a transformative impact on Illumina's product portfolio.My success as a Bioinformatics Scientist is underscored by significant improvements in core variant annotation speed, reduction of HGVS issues, and the creation of scalable, cost-effective solutions capable of processing millions of cases. I've led comprehensive evaluations of oncology knowledge bases, contributing to strategic decision-making in precision oncology initiatives. Beyond these, my leadership extends to managing teams that develop algorithms for medically relevant products.Before Illumina, I developed MOSAIK, an ultra-fast, versatile Next-Generation Sequencing (NGS) aligner, during my time at Boston College. I also contributed to significant projects such as the 1000 Genomes Project. My bioinformatics experience began at KTH and Harvard University, where I developed software tools for advanced data analysis and research.Parallel to my work in bioinformatics, I have a rich background in software development. As a co-founder at Alecti Group, I was involved in systems design with a focus on data integrity and security. In my early career, I leveraged my technical skills to support the Swedish National Police in a high-profile case, creating a custom high-performance password cracker.My expertise extends beyond pure science and technology to include leadership, collaboration, and the ability to establish successful partnerships. I am passionate about leveraging data and technology to improve healthcare and clinical diagnostics. As a visionary and a pragmatic executor, I am always ready to tackle the next challenging problem in genomics and bioinformatics.